Inicio>>Signaling Pathways>> GPCR/G protein>> Prostaglandin Receptor>>trans-Isoferulic acid

trans-Isoferulic acid

Catalog No.GC71862

trans-Isoferulic acid (ácido trans-3-hidroxi4-metoxicinnamic) es un ácido aromático aislado de las raíces de Clematis Florida var. plena. trans-Isoferulic acid exhibe actividad antiinflamatoria.

Products are for research use only. Not for human use. We do not sell to patients.

trans-Isoferulic acid Chemical Structure

Cas No.: 25522-33-2

Tamaño Precio Disponibilidad Cantidad
100 mg
23,00 $
Disponible
250 mg
45,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
trans-Isoferulic acid (trans-3-Hydroxy-4-methoxycinnamic acid) is an aromatic acid isolated from the roots of Clematis florida var. plena. trans-Isoferulic acid exhibits anti-inflammatory activity.trans-isoferulic acid suppresses NO and PGE2 production through the induction of Nrf2-dependent heme oxygenase-1 (HO-1).

References:
[1]. Kai-Hui Sun, et al. A new indole-type alkaloid from the roots of Clematis florida var. plena. Nat Prod Res. 2019 Oct;33(20):2925-2931.
[2]. Matharage Gayani Dilshara, et al. Downregulation of NO and PGE2 in LPS-stimulated BV2 microglial cells by trans-isoferulic acid via suppression of PI3K/Akt-dependent NF-κB and activation of Nrf2-mediated HO-1. Int Immunopharmacol. 2014 Jan;18(1):203-11.

Reseñas

Review for trans-Isoferulic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for trans-Isoferulic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.